Stress prophylaxis in intensive care unit patients and the role of enteral nutrition

Journal of Parenteral and Enteral Nutrition

Volumn 36, Issue 6, 2012, Pages 721-731

  Hurt, Ryan T ^a,b   Frazier, Thomas H ^b   McClave, Stephen A ^b   Crittenden, Neil E ^b   Kulisek, Christopher ^b   Saad, Mohamed ^b   Franklin, Glen A ^b  

^a MAYO CLINIC   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

acid suppressive therapy; enteral nutrition; stress prophylaxis

Indexed keywords

ANTACID AGENT; ARGININE; CYCLOOXYGENASE 2; ENDOTHELIN 1; NITRIC OXIDE;

ARTIFICIAL VENTILATION; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SEVERITY; DRUG SAFETY; ENTERIC FEEDING; ENZYME ACTIVATION; GASTROINTESTINAL HEMORRHAGE; HUMAN; INAPPROPRIATE PRESCRIBING; INTENSIVE CARE; MUCOSAL BLEEDING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION INJURY; REVIEW; STOMACH ACID; STOMACH BLOOD FLOW; STOMACH DISEASE; STOMACH PROTECTION; STRESS GASTROPATHY; STRESS ULCER;

ANTI-ULCER AGENTS; ENTERAL NUTRITION; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; PEPTIC ULCER; STRESS, PHYSIOLOGICAL;

EID: 84867654685     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607112436978     Document Type: Review

References (103)

1. Ali T, Harty RF. Stress-induced ulcer bleeding in critically ill patients. Gastroenterol Clin North Am. 2009 ; 38 (2). 245-265
2. Klebl FH, Scholmerich J. Future expectations in the prophylaxis of intestinal bleeding. Best Pract Res Clin Gastroenterol. 2008 ; 22 (2). 373-387
3. Tryba M, Cook D. Current guidelines on stress ulcer prophylaxis. Drugs. 1997 ; 54 (4). 581-596
4. Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006 ; 296 (24). 2947-2953
5. Heidelbaugh JJ, Goldberg KL, Inadomi JM. Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected]. Am J Gastroenterol. 2009 ; 104: S27 - S32
6. BartholowM. Top drugs of 2010. http://www.pharmacytimes.com/publications/ issue/2011/May2011/Top-200-Drugs-of-2010. Accessed October 25, 2011.
7. Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med. 1994 ; 330 (6). 377-381
8. Ellison RT, Perez-Perez G, Welsh CH, et al. Risk factors for upper gastrointestinal bleeding in intensive care unit patients: role of Helicobacter pylori. Federal Hyperimmune Immunoglobulin Therapy Study Group. Crit Care Med. 1996 ; 24 (12). 1974-1981
9. Cook DJ, Griffith LE, Walter SD, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care. 2001 ; 5 (6). 368-375
10. Mutlu GM, Mutlu EA, Factor P. GI complications in patients receiving mechanical ventilation. Chest. 2001 ; 119 (4). 1222-1241
11. Beejay U, Wolfe MM. Acute gastrointestinal bleeding in the intensive care unit: the gastroenterologist's perspective. Gastroenterol Clin North Am. 2000 ; 29 (2). 309-336
12. Fennerty MB. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression. Crit Care Med. 2002 ; 30 (6). S351 - S355
13. Sesler JM. Stress-related mucosal disease in the intensive care unit: an update on prophylaxis. AACN Adv Crit Care. 2007 ; 18 (2). 119-126
14. Metz DC. Preventing the gastrointestinal consequences of stress-related mucosal disease. Curr Med Res Opin. 2005 ; 21 (1). 11-18
15. Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology. 2008 ; 135 (1). 41-60
16. Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care. 2005 ; 20 (1). 35-45
17. Leung FW, Itoh M, Hirabayashi K, Guth PH. Role of blood flow in gastric and duodenal mucosal injury in the rat. Gastroenterology. 1985 ; 88 (1). 281-289
18. Yasue N, Guth PH. Role of exogenous acid and retransfusion in hemorrhagic shock-induced gastric lesions in the rat. Gastroenterology. 1988 ; 94 (5). 1135-1143
19. Maynard N, Bihari D, Beale R, et al. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA. 1993 ; 270 (10). 1203-1210
20. Spirt MJ. Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther. 2004 ; 26 (2). 197-213
21. Kamada T, Sato N, Kawano S, Fusamoto H, Abe H. Gastric mucosal hemodynamics after thermal or head injury: a clinical application of reflectance spectrophotometry. Gastroenterology. 1982 ; 83 (3). 535-540
22. Spirt MJ, Guth PH, Randall G, Leung FW. Gastroduodenal perfusion and mortality in mechanical ventilation-dependent patients with systemic inflammatory response syndrome. Dig Dis Sci. 2004 ; 49 (6). 906-913
23. Matheson PJ, Hurt RT, Franklin GA, McClain CJ, Garrison RN. Obesity-induced hepatic hypoperfusion primes for hepatic dysfunction after resuscitated hemorrhagic shock. Surgery. 2009 ; 146 (4). 739-747
24. Hurt RT, Zakaria el R, Matheson PJ, Cobb ME, Parker JR, Garrison RN. Hemorrhage-induced hepatic injury and hypoperfusion can be prevented by direct peritoneal resuscitation. J Gastrointest Surg. 2009 ; 13 (4). 587-594
25. Zakaria el R, Hurt RT, Matheson PJ, Garrison RN. A novel method of peritoneal resuscitation improves organ perfusion after hemorrhagic shock. Am J Surg. 2003 ; 186 (5). 443-448
26. Zakaria el R, Garrison RN, Spain DA, Matheson PJ, Harris PD, Richardson JD. Intraperitoneal resuscitation improves intestinal blood flow following hemorrhagic shock. Ann Surg. 2003 ; 237 (5). 704-711
27. Matheson PJ, Wilson MA, Garrison RN. Regulation of intestinal blood flow. J Surg Res. 2000 ; 93 (1). 182-196
28. Kobata A, Kotani T, Komatsu Y, Amagase K, Kato S, Takeuchi K. Dual action of nitric oxide in the pathogenesis of ischemia/reperfusion-induced mucosal injury in mouse stomach. Digestion. 2007 ; 75 (4). 188-197
29. Wada K, Kamisaki Y, Ohkura T, et al. Direct measurement of nitric oxide release in gastric mucosa during ischemia-reperfusion in rats. Am J Physiol. 1998 ; 274 (3). G465 - G471
30. Michida T, Kawano S, Masuda E, et al. Endothelin-1 in the gastric mucosa in stress ulcers of critically ill patients. Am J Gastroenterol. 1997 ; 92 (7). 1177-1181
31. Maricic N, Ehrlich K, Gretzer B, Schuligoi R, Respondek M, Peskar BM. Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach. Br J Pharmacol. 1999 ; 128 (8). 1659-1666
32. Kotani T, Kobata A, Nakamura E, Amagase K, Takeuchi K. Roles of cyclooxygenase-2 and prostacyclin/IP receptors in mucosal defense against ischemia/reperfusion injury in mouse stomach. J Pharmacol Exp Ther. 2006 ; 316 (2). 547-555
33. Das D, Bandyopadhyay D, Bhattacharjee M, Banerjee RK. Hydroxyl radical is the major causative factor in stress-induced gastric ulceration. Free Radic Biol Med. 1997 ; 23 (1). 8-18
34. Zollei I. Experimental study of hypovolaemic shock-induced gastric mucosal lesions in the rat. Ann Acad Med Singapore. 1999 ; 28 (1). 85-89
35. Tanaka J, Yuda Y. Role of lipid peroxidation in gastric mucosal lesions induced by ischemia-reperfusion in the pylorus-ligated rat. Biol Pharm Bull. 1993 ; 16 (1). 29-32
36. Jia YT, Wei W, Ma B, et al. Activation of p38 MAPK by reactive oxygen species is essential in a rat model of stress-induced gastric mucosal injury. J Immunol. 2007 ; 179 (11). 7808-7819
37. Peterson WL, Cook DJ. Antisecretory therapy for bleeding peptic ulcer. JAMA. 1998 ; 280 (10). 877-878
38. Wadibia EC, Lucas BD, Hilleman DE, Mooss AN. Economic impact of inappropriate histamine2-receptor antagonist use. Clin Ther. 1997 ; 19 (5). 1085-1091
39. Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol. 2000 ; 95 (11). 3118-3122
40. Zink DA, Pohlman M, Barnes M, Cannon ME. Long-term use of acid suppression started inappropriately during hospitalization. Aliment Pharmacol Ther. 2005 ; 21 (10). 1203-1209
41. Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol. 2006 ; 101 (10). 2200-2205
42. Bajaj JS, Zadvornova Y, Heuman DM, et al. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterol. 2009 ; 104 (5). 1130-1134
43. Vakil N. Acid inhibition and infections outside the gastrointestinal tract. Am J Gastroenterol. 2009 ; 104: S17 - S20
44. Miano TA, Reichert MG, Houle TT, MacGregor DA, Kincaid EH, Bowton DL. Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients. Chest. 2009 ; 136 (2). 440-447
45. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA. 2009 ; 301 (20). 2120-2128
46. Roughead EE, Ramsay EN, Pratt NL, Ryan P, Gilbert AL. Proton-pump inhibitors and the risk of antibiotic use and hospitalisation for pneumonia. Med J Aust. 2009 ; 190 (3). 114-116
47. Sarkar M, Hennessy S, Yang YX. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med. 2008 ; 149 (6). 391-398
48. Dial S, Kezouh A, Dascal A, Barkun A, Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ. 2008 ; 179 (8). 767-772
49. Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol. 2007 ; 102 (9). 2047-2056
50. Aseeri M, Schroeder T, Kramer J, Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol. 2008 ; 103 (9). 2308-2313
51. Cunningham R, Dial S. Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea?. J Hosp Infect. 2008 ; 70 (1). 1-6
52. Dalton BR, Lye-Maccannell T, Henderson EA, Maccannell DR, Louie TJ. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting. Aliment Pharmacol Ther. 2009 ; 29 (6). 626-634
53. Dial MS. Proton pump inhibitor use and enteric infections. Am J Gastroenterol. 2009 ; 104: S10 - S16
54. Howden CW, Hunt RH. Relationship between gastric secretion and infection. Gut. 1987 ; 28 (1). 96-107
55. Tennant SM, Hartland EL, Phumoonna T, et al. Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens. Infect Immun. 2008 ; 76 (2). 639-645
56. Martinsen TC, Bergh K, Waldum HL. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol. 2005 ; 96 (2). 94-102
57. Parkman HP, Urbain JL, Knight LC, et al. Effect of gastric acid suppressants on human gastric motility. Gut. 1998 ; 42 (2). 243-250
58. Goddard AF, Spiller RC. The effect of omeprazole on gastric juice viscosity, pH and bacterial counts. Aliment Pharmacol Ther. 1996 ; 10 (1). 105-109
59. Dinsmore JE, Jackson RJ, Smith SD. The protective role of gastric acidity in neonatal bacterial translocation. J Pediatr Surg. 1997 ; 32 (7). 1014-1016
60. Lewis SJ, Franco S, Young G, O'Keefe SJ. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther. 1996 ; 10 (4). 557-561
61. Williams C, McColl KE. Review article: proton pump inhibitors and bacterial overgrowth. Aliment Pharmacol Ther. 2006 ; 23 (1). 3-10
62. Yoshida N, Yoshikawa T, Tanaka Y, et al. A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther. 2000 ; 14: 74-81
63. Zedtwitz-Liebenstein K, Wenisch C, Patruta S, Parschalk B, Daxbock F, Graninger W. Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity. Crit Care Med. 2002 ; 30 (5). 1118-1122
64. Agastya G, West BC, Callahan JM. Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitro. Immunopharmacol Immunotoxicol. 2000 ; 22 (2). 357-372
65. Barbut F, Petit JC. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect. 2001 ; 7 (8). 405-410
66. Kaur S, Vaishnavi C, Prasad KK, Ray P, Kochhar R. Comparative role of antibiotic and proton pump inhibitor in experimental Clostridium difficile infection in mice. Microbiol Immunol. 2007 ; 51 (12). 1209-1214
67. Jump RL, Pultz MJ, Donskey CJ. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea?. Antimicrob Agents Chemother. 2007 ; 51 (8). 2883-2887
68. Nerandzic MM, Pultz MJ, Donskey CJ. Examination of potential mechanisms to explain the association between proton pump inhibitors and Clostridium difficile infection. Antimicrob Agents Chemother. 2009 ; 53 (10). 4133-4137
69. Torres A, El-Ebiary M, Soler N, Monton C, Fabregas N, Hernandez C. Stomach as a source of colonization of the respiratory tract during mechanical ventilation: association with ventilator-associated pneumonia. Eur Respir J. 1996 ; 9 (8). 1729-1735
70. Nealis TB, Howden CW. Is there a dark side to long-term proton pump inhibitor therapy?. Am J Ther. 2008 ; 15 (6). 536-542
71. Cote GA, Howden CW. Potential adverse effects of proton pump inhibitors. Curr Gastroenterol Rep. 2008 ; 10 (3). 208-214
72. Ali T, Roberts DN, Tierney WM. Long-term safety concerns with proton pump inhibitors. Am J Med. 2009 ; 122 (10). 896-903
73. Sultan N, Nazareno J, Gregor J. Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials. Can J Gastroenterol. 2008 ; 22 (9). 761-766
74. Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA. 2004 ; 292 (16). 1955-1960
75. Gulmez SE, Holm A, Frederiksen H, Jensen TG, Pedersen C, Hallas J. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med. 2007 ; 167 (9). 950-955
76. Mallow S, Rebuck JA, Osler T, Ahern J, Healey MA, Rogers FB. Do proton pump inhibitors increase the incidence of nosocomial pneumonia and related infectious complications when compared with histamine-2 receptor antagonists in critically ill trauma patients?. Curr Surg. 2004 ; 61 (5). 452-458
77. Rhoden D, Matheson PJ, Carricato ND, Spain DA, Garrison RN. Immune-enhancing enteral diet selectively augments ileal blood flow in the rat. J Surg Res. 2002 ; 106 (1). 25-30
78. Matheson PJ, Harris BT, Hurt RT, Zakaria ER, Garrison RN. Enteral glutamine supplementation impairs intestinal blood flow in rats. Am J Surg. 2008 ; 196 (2). 293-299
79. Matheson PJ, Hurt RT, Mittel OF, Wilson MA, Spain DA, Garrison RN. Immune-enhancing enteral diet increases blood flow and proinflammatory cytokines in the rat ileum. J Surg Res. 2003 ; 110 (2). 360-370
80. Matheson PJ, Lusco V, Wilson MA, Garrison RN. Omega-3 fatty acids in immune-enhancing enteral diets selectively increase blood flow to the ileum by a bile acid dependent mechanism. Surgery. 2002 ; 132 (4). 673-680
81. Yan H, Peng X, Huang Y, Zhao M, Li F, Wang P. Effects of early enteral arginine supplementation on resuscitation of severe burn patients. Burns. 2007 ; 33 (2). 179-184
82. MacLaren R, Jarvis CL, Fish DN. Use of enteral nutrition for stress ulcer prophylaxis. Ann Pharmacother. 2001 ; 35 (12). 1614-1623
83. Bonten MJ, Gaillard CA, van Tiel FH, van der Geest S, Stobberingh EE. Continuous enteral feeding counteracts preventive measures for gastric colonization in intensive care unit patients. Crit Care Med. 1994 ; 22 (6). 939-944
84. Rigaud D, Chastre J, Accary JP, Bonfils S, Gibert C, Hance AJ. Intragastric pH profile during acute respiratory failure in patients with chronic obstructive pulmonary disease: effect of ranitidine and enteral feeding. Chest. 1986 ; 90 (1). 58-63
85. Heyland DK, Cook DJ, Schoenfeld PS, Frietag A, Varon J, Wood G. The effect of acidified enteral feeds on gastric colonization in critically ill patients: results of a multicenter randomized trial. Canadian Critical Care Trials Group. Crit Care Med. 1999 ; 27 (11). 2399-2406
86. Heyland D, Bradley C, Mandell LA. Effect of acidified enteral feedings on gastric colonization in the critically ill patient. Crit Care Med. 1992 ; 20 (10). 1388-1394
87. Bonten MJ, Gaillard CA, van der Hulst R, et al. Intermittent enteral feeding: the influence on respiratory and digestive tract colonization in mechanically ventilated intensive-care-unit patients. Am J Respir Crit Care Med. 1996 ; 154 (2). 394-399
88. Spilker CA, Hinthorn DR, Pingleton SK. Intermittent enteral feeding in mechanically ventilated patients: the effect on gastric pH and gastric cultures. Chest. 1996 ; 110 (1). 243-248
89. Bonten MJ, Gaillard CA, van der Geest S, et al. The role of intragastric acidity and stress ulcus prophylaxis on colonization and infection in mechanically ventilated ICU patients: a stratified, randomized, double-blind study of sucralfate versus antacids. Am J Respir Crit Care Med. 1995 ; 152 (6). 1825-1834
90. Pingleton SK, Hinthorn DR, Liu C. Enteral nutrition in patients receiving mechanical ventilation: multiple sources of tracheal colonization include the stomach. Am J Med. 1986 ; 80 (5). 827-832
91. Valentine RJ, Turner WW, Borman KR, Weigelt JA. Does nasoenteral feeding afford adequate gastroduodenal stress prophylaxis?. Crit Care Med. 1986 ; 14 (7). 599-601
92. Watson LC, Abston S. Prevention of upper gastrointestinal hemorrhage in 582 burned children. Am J Surg. 1976 ; 132 (6). 790-793
93. Yan R, Sun Y, Sun R. Early enteral feeding and supplement of glutamine prevent occurrence of stress ulcer following severe thermal injury [in Chinese]. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi. 1995 ; 11 (3). 189-192
94. Zandstra DF, Stoutenbeek CP. The virtual absence of stress-ulceration related bleeding in ICU patients receiving prolonged mechanical ventilation without any prophylaxis: a prospective cohort study. Intensive Care Med. 1994 ; 20 (5). 335-340
95. Pingleton SK, Hadzima SK. Enteral alimentation and gastrointestinal bleeding in mechanically ventilated patients. Crit Care Med. 1983 ; 11 (1). 13-16
96. Solem LD, Strate RG, Fischer RP. Antacid therapy and nutritional supplementation in the prevention of Curling's ulcer. Surg Gynecol Obstet. 1979 ; 148 (3). 367-370
97. Raff T, Germann G, Hartmann B. The value of early enteral nutrition in the prophylaxis of stress ulceration in the severely burned patient. Burns. 1997 ; 23 (4). 313-318
98. Gurman G, Samri M, Sarov B, Bearman JE, Heilig I. The rate of gastrointestinal bleeding in a general ICU population: a retrospective study. Intensive Care Med. 1990 ; 16 (1). 44-49
99. Devlin JW, Ben-Menachem T, Ulep SK, Peters MJ, Fogel RP, Zarowitz BJ. Stress ulcer prophylaxis in medical ICU patients: annual utilization in relation to the incidence of endoscopically proven stress ulceration. Ann Pharmacother. 1998 ; 32 (9). 869-874
100. Devlin JW, Claire KS, Dulchavsky SA, Tyburski JG. Impact of trauma stress ulcer prophylaxis guidelines on drug cost and frequency of major gastrointestinal bleeding. Pharmacotherapy. 1999 ; 19 (4). 452-460
101. Marik PE, Vasu T, Hirani A, Pachinburavan M. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis. Crit Care Med. 2010 ; 38 (11). 2222-2228
102. Apte NM, Karnad DR, Medhekar TP, Tilve GH, Morye S, Bhave GG. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial. Crit Care Med. 1992 ; 20 (5). 590-593
103. Ben-Menachem T, Fogel R, Patel RV, et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit: a randomized, controlled, single-blind study. Ann Intern Med. 1994 ; 121 (8). 568-575